Article

Sodium Tanshinone IIA Sulfonate Prevents Angiotensin II-Induced Differentiation of Human…

Oxidative Medicine and Cellular Longevity · 2018 · Tangting Chen, author Miaoling Li, author Xuehui Fan, author Jun Cheng, author Liqun Wang, author Ryuichi Morishita, Academic Editor

Key facts

Title Sodium Tanshinone IIA Sulfonate Prevents Angiotensin II-Induced Differentiation of Human Atrial Fibroblasts into Myofibroblasts
First author Tangting Chen, author Miaoling Li, author Xuehui Fan, author Jun Cheng, author Liqun Wang, author Ryuichi Morishita, Academic Editor
Journal Oxidative Medicine and Cellular Longevity
Published Apr 17, 2018
DOI 10.1155/2018/6712585
Devices mentioned K973350, K990827
Product codes mentioned JLX, KQP

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature